|
|
|
|
|
By Kara Quinn and Ewelina Flamm | Nothing is risk-free. Now more than ever, all sourcing options have pros and cons that we need to assess to find the best fit. In this first article of a two-part series, we share three compelling reasons to consider outsourcing, along with key considerations for each. |
|
|
|
|
| Delivering Genetic Editing Therapies To Market | Article | By Dr. Rajiv Vaidya and Dr. Samir Acharya, Andelyn Biosciences | Manufacturers with proven expertise in areas such as viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients. |
|
|
| Growing With A Flexible, Collaborative CDMO | Article | By Kim Berger and Paul Magreta, CHIRON® Recombinant Proteins | Choosing a CDMO that is agile, innovative, and exhibits a willingness to invest in new equipment, infrastructure, and services will allow the innovator company and the CDMO to grow together. |
|
|
|
|
| Faster R&D Of Pharma Production Lines | Case Study | Seeq Corporation | This use case demonstrates a solution that empowers users by connecting to all relevant data sources to visually represent batches and perform analytics with process data. |
|
|
|
|
| Strategies, Emerging Technologies For mAb Capture | Webinar | Cytiva | Explore opportunities with the introduction of high-capacity protein A resins, how and when multicolumn chromatography is beneficial, and how emerging technologies can address bottlenecks. |
|
|
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|
Connect With Bioprocess Online: |
|
|
|